These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34051979)

  • 1. Phenomapping Heart Failure with Preserved Ejection Fraction Using Machine Learning Cluster Analysis: Prognostic and Therapeutic Implications.
    Galli E; Bourg C; Kosmala W; Oger E; Donal E
    Heart Fail Clin; 2021 Jul; 17(3):499-518. PubMed ID: 34051979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Status of Pharmacologic and Nonpharmacologic Therapy in Heart Failure with Preserved Ejection Fraction.
    Kim MN; Park SM
    Heart Fail Clin; 2021 Jul; 17(3):463-482. PubMed ID: 34051977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of the PACIFIC-PRESERVED (PhenomApping, ClassIFication and Innovation for Cardiac dysfunction in patients with heart failure and PRESERVED left ventricular ejection fraction) study.
    Hulot JS; Janiak P; Boutinaud P; Boutouyrie P; Chézalviel-Guilbert F; Christophe JJ; Cohen A; Damy T; Djadi-Prat J; Firat H; Hervé PY; Isnard R; Jondeau G; Mousseaux E; Pernot M; Prot P; Tyl B; Soulat G; Logeart D;
    Arch Cardiovasc Dis; 2024 May; 117(5):332-342. PubMed ID: 38644067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenomapping for novel classification of heart failure with preserved ejection fraction.
    Shah SJ; Katz DH; Selvaraj S; Burke MA; Yancy CW; Gheorghiade M; Bonow RO; Huang CC; Deo RC
    Circulation; 2015 Jan; 131(3):269-79. PubMed ID: 25398313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis.
    Segar MW; Patel KV; Ayers C; Basit M; Tang WHW; Willett D; Berry J; Grodin JL; Pandey A
    Eur J Heart Fail; 2020 Jan; 22(1):148-158. PubMed ID: 31637815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions.
    Peters AE; Tromp J; Shah SJ; Lam CSP; Lewis GD; Borlaug BA; Sharma K; Pandey A; Sweitzer NK; Kitzman DW; Mentz RJ
    Cardiovasc Res; 2023 Feb; 118(18):3403-3415. PubMed ID: 36448685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Heart Failure with Preserved Ejection Fraction: Current Challenges and Future Directions.
    Upadhya B; Kitzman DW
    Am J Cardiovasc Drugs; 2017 Aug; 17(4):283-298. PubMed ID: 28316006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction.
    Chen X; Savarese G; Dahlström U; Lund LH; Fu M
    Clin Res Cardiol; 2019 Dec; 108(12):1394-1405. PubMed ID: 30980205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
    Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
    Heart; 2018 Mar; 104(6):525-532. PubMed ID: 28982721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications.
    Stolfo D; Uijl A; Vedin O; Strömberg A; Faxén UL; Rosano GMC; Sinagra G; Dahlström U; Savarese G
    JACC Heart Fail; 2019 Jun; 7(6):505-515. PubMed ID: 31146874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short and long-term prognostic value of hyponatremia in heart failure with preserved ejection fraction versus reduced ejection fraction: An analysis of the Korean Acute Heart Failure registry.
    Park JJ; Cho YJ; Oh IY; Park HA; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    Int J Cardiol; 2017 Dec; 248():239-245. PubMed ID: 28821416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ankle-brachial index and incident heart failure with reduced versus preserved ejection fraction: The Multi-Ethnic Study of Atherosclerosis.
    Prasada S; Shah SJ; Michos ED; Polak JF; Greenland P
    Vasc Med; 2019 Dec; 24(6):501-510. PubMed ID: 31480898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.
    Salah K; Stienen S; Pinto YM; Eurlings LW; Metra M; Bayes-Genis A; Verdiani V; Tijssen JGP; Kok WE
    Heart; 2019 Aug; 105(15):1182-1189. PubMed ID: 30962192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
    Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
    Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
    Savarese G; Vedin O; D'Amario D; Uijl A; Dahlström U; Rosano G; Lam CSP; Lund LH
    JACC Heart Fail; 2019 Apr; 7(4):306-317. PubMed ID: 30852236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenomapping for the Identification of Hypertensive Patients with the Myocardial Substrate for Heart Failure with Preserved Ejection Fraction.
    Katz DH; Deo RC; Aguilar FG; Selvaraj S; Martinez EE; Beussink-Nelson L; Kim KA; Peng J; Irvin MR; Tiwari H; Rao DC; Arnett DK; Shah SJ
    J Cardiovasc Transl Res; 2017 Jun; 10(3):275-284. PubMed ID: 28258421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of Cardiovascular Reserve to Prognostic Categories of Heart Failure With Preserved Ejection Fraction: A Classification Based on Machine Learning.
    Przewlocka-Kosmala M; Marwick TH; Dabrowski A; Kosmala W
    J Am Soc Echocardiogr; 2019 May; 32(5):604-615.e6. PubMed ID: 30718020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.